Neumeister, Veronique <br/><br/>
In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.  [electronic resource] 

 -  The American journal of pathology  May 2010 
 - 2131-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1525-2191 
<br/><br/><label>Standard No.: </label>10.2353/ajpath.2010.090712  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Aldehyde Dehydrogenase--metabolism<br/>Aldehyde Dehydrogenase 1 Family<br/>Breast Neoplasms--metabolism<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Hyaluronan Receptors--metabolism<br/>Isoenzymes--metabolism<br/>Keratins--metabolism<br/>Middle Aged<br/>Neoplastic Stem Cells--cytology<br/>Prognosis<br/>Retinal Dehydrogenase<br/>Retrospective Studies